By qRT-PCR validation, MM patients with 1q+ had significantly higher levels of IGF2BP1 mRNA (Fig. 1E; P = 0.045), while MM patients with t(4;14) failed to reach statistical significance. The gene discussed is IGF2BP1; the disease is Miyoshi myopathy.